← Leaderboards
Lawrence A Vernetti
University Of Pittsburgh At Pittsburgh
$500,816
Attributed
$625,816
Total exposure
2
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2M · FY2024–25$2.5M$1.9M$1.3M$625K$0
'24
'25
Funding mix
By agency
NIH$3,477,988 · 2
FDA$250,000 · 1
By mechanism
U2C$3,477,988 · 2
U01$250,000 · 1
Top collaborators
- Mark E Schurdak3 shared
- Mark T. Miedel2 shared
- Alejandro Soto-Gutierrez2 shared
- D. Lansing Taylor2 shared
Most similar at University Of Pittsburgh At Pittsburgh
Same institution · by research overlap
- Wen Xie$22,052,503
- Jiantao Pu$7,235,980
- Jaideep Behari$4,660,334
- John S Lazo$20,744,955
- Stephen A Murray$43,730,323
Others in their field
Other Rising Stars on “Hepatic”
- Michael George Natchus · Emory University$10,548,554
- Alexander Kolykhalov · Emory University$8,116,465
- Timothy O'Connor · Rockefeller University$7,019,416
- Julian A Symons · Hackensack University Medical Center$4,228,031
- Sean B. Joseph · Scripps Research Institute, The$4,224,287
- Amar Nijagal · University Of California, San Francisco$3,176,680
Research focus
HepaticInduced Pluripotent Stem CellDrug TestingFutureBiomimeticsAutomationDrug EfficacyDrug MetabolismEfficacy TestingFatty LiverClinical TrialsCohortCollaborationsCommercializationCellsDrug DiscoveryBackComputational BiologyComputer ModelsCellular BiologyClinicEnsureDrug DevelopmentInformatics
Grant awards (5)
Qualification of Patient-Derived Biomimetic Liver MPS as Drug Discovery Tools for Drug Metabolism, Toxicity, Drug Efficacy Testing and Clinical Trial Cohort Selection$1,540,258
U2C · FY2025 · TR
DDT-IST-000034 Liver acinus microphysiological systems (LAMPS) for determining drug candidate dosing in clinical trials of liver disease.$250,000
U01 · FY2025 · FD
MPS Resources Section$215,550
U2C · FY2025 · TR · contact PI
Qualification of Patient-Derived Biomimetic Liver MPS as Drug Discovery Tools for Drug Metabolism, Toxicity, Drug Efficacy Testing and Clinical Trial Cohort Selection$1,561,914
U2C · FY2024 · TR
MPS Resources Section$160,266
U2C · FY2024 · TR · contact PI